Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Downregulation of the CCK-B Receptor in Pancreatic Stellate Cells Blocks Molecular Proliferative Pathways and Increases Apoptosis to Decrease Pancreatic Cancer Growth In Vitro.
Journal: International journal of molecular sciences
Published: October 14, 2025
Mechanistic Insights into Proglumide's Role in Immune Cell Efficacy and Response to Immune Checkpoint Inhibitor Therapy in Hepatocellular Carcinoma.
Journal: Cancers
Published: August 17, 2025
Interruption of cross-communication pathways alters the immune cell signature of pancreatic cancer and decreases tumor growth.
Journal: Cell communication and signaling : CCS
Published: August 01, 2025
Genetic Distinctiveness in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma Cancer: Identifying Key Genomic Signatures through Differentially Expressed Gene Analysis.
Journal: Current cancer drug targets
Published: December 09, 2024
Target-Specific Locked Nucleic Acid Gapmer Decreases Growth and Metastases of Pancreatic Cancer.
Journal: Molecular cancer therapeutics
Published: November 15, 2024
Implicating the cholecystokinin B receptor in liver stem cell oncogenesis.
Journal: American journal of physiology. Gastrointestinal and liver physiology
Published: January 22, 2024
Cholecystokinin Receptor Antagonist Induces Pancreatic Stellate Cell Plasticity Rendering the Tumor Microenvironment Less Oncogenic.
Journal: Cancers
Published: March 11, 2023
Treatment with a Cholecystokinin Receptor Antagonist, Proglumide, Improves Efficacy of Immune Checkpoint Antibodies in Hepatocellular Carcinoma.
Journal: International journal of molecular sciences
Published: November 21, 2022
Target-Specific Nanoparticle Polyplex Down-Regulates Mutant Kras to Prevent Pancreatic Carcinogenesis and Halt Tumor Progression.
Journal: International journal of molecular sciences
Published: November 20, 2022
Gastrin Vaccine Alone and in Combination With an Immune Checkpoint Antibody Inhibits Growth and Metastases of Gastric Cancer.
Journal: Frontiers in oncology
Published: October 03, 2021
Last Updated: 09/26/2026